New Colchicine Product and Dosing Regimen

FDA has approved the first single-ingredient oral colchicine product. The drug, called Colcrys, is approved to treat acute gout flares and familial Mediterranean fever. Oral colchicine has been used to treat gout in the past, but until now it had not been approved by FDA. Colchicine has historically been given every hour for acute gout flares, either until the flare subsided or treatment had to be stopped because the patient developed gastrointestinal problems. But a dosing study conducted ...
Author: USFoodandDrugAdmin; Tags: Colcrys gout familial Mediterranean fever clarithromycin cyclosporine FMF drug FDA











